These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2036479)

  • 21. A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's disease.
    Pfefferbaum A; Sullivan EV; Jernigan TL; Zipursky RB; Rosenbloom MJ; Yesavage JA; Tinklenberg JR
    Psychiatry Res; 1990 Dec; 35(2):115-36. PubMed ID: 2100804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal study of cerebral blood flow in Alzheimer's disease using single photon emission tomography.
    Sachdev P; Gaur R; Brodaty H; Walker A; Meares S; Koder D; Haindl W
    Psychiatry Res; 1997 Feb; 68(2-3):133-41. PubMed ID: 9104760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of cerebral ventricular dilation and cognitive function in patients with Alzheimer's disease of early versus late onset.
    Kono K; Kuzuya F; Yamamoto T; Endo H
    J Geriatr Psychiatry Neurol; 1994; 7(1):39-45. PubMed ID: 8192829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shape changes of the basal ganglia and thalamus in Alzheimer's disease: a three-year longitudinal study.
    Cho H; Kim JH; Kim C; Ye BS; Kim HJ; Yoon CW; Noh Y; Kim GH; Kim YJ; Kim JH; Kim CH; Kang SJ; Chin J; Kim ST; Lee KH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2014; 40(2):285-95. PubMed ID: 24413620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
    Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
    J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease.
    Hanaoka T; Kimura N; Aso Y; Takemaru M; Kimura Y; Ishibashi M; Matsubara E
    Geriatr Gerontol Int; 2016 Jul; 16(7):836-42. PubMed ID: 26245516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of cognitive impairment in Alzheimer's disease.
    Burns A; Jacoby R; Levy R
    J Am Geriatr Soc; 1991 Jan; 39(1):39-45. PubMed ID: 1987255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings.
    Förstl H; Burns A; Luthert P; Cairns N; Levy R
    Br J Psychiatry; 1993 Mar; 162():385-92. PubMed ID: 8453435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.
    Tanaka S; Kawamata J; Shimohama S; Akaki H; Akiguchi I; Kimura J; Ueda K
    Dement Geriatr Cogn Disord; 1998; 9(2):90-8. PubMed ID: 9524800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quantitative study of intracranial calcification in dementia of the Alzheimer type.
    Friedland RP; Luxenberg JS; Koss E
    Int Psychogeriatr; 1990; 2(1):36-43. PubMed ID: 2101296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease.
    Starkstein SE; Sabe L; Vazquez S; Teson A; Petracca G; Chemerinski E; Di Lorenzo G; Leiguarda R
    Stroke; 1996 Mar; 27(3):408-14. PubMed ID: 8610304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis.
    Aharon-Peretz J; Cummings JL; Hill MA
    Arch Neurol; 1988 Jul; 45(7):719-21. PubMed ID: 3260480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder.
    Borroni B; Premi E; Agosti C; Alberici A; Cerini C; Archetti S; Lanari A; Paghera B; Lucchini S; Caimi L; Padovani A
    J Neurol Neurosurg Psychiatry; 2011 Aug; 82(8):834-8. PubMed ID: 21345847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease.
    Lopez OL; Becker JT; Jungreis CA; Rezek D; Estol C; Boller F; DeKosky ST
    Arch Neurol; 1995 Jul; 52(7):659-64. PubMed ID: 7619020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of the NINCDS-ADRDA neuropsychological criteria for the assessment of Alzheimer's disease: a confirmatory factor analysis of single versus multi-factor models.
    Loewenstein DA; Ownby R; Schram L; Acevedo A; Rubert M; Argüelles T
    J Clin Exp Neuropsychol; 2001 Jun; 23(3):274-84. PubMed ID: 11404806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease.
    Costa AS; Reich A; Fimm B; Ketteler ST; Schulz JB; Reetz K
    Dement Geriatr Cogn Disord; 2014; 37(1-2):95-103. PubMed ID: 24107412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.